Addex Therapeutics Ltd (ADXN)
8.23
+0.85
(+11.52%)
USD |
NASDAQ |
Nov 21, 16:00
8.23
0.00 (0.00%)
After-Hours: 19:51
Addex Therapeutics Price to Book Value: 0.6249 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 0.5604 |
November 19, 2024 | 0.6052 |
November 18, 2024 | 0.6007 |
November 15, 2024 | 0.612 |
November 14, 2024 | 0.6227 |
November 13, 2024 | 0.6553 |
November 12, 2024 | 0.666 |
November 11, 2024 | 0.8186 |
November 08, 2024 | 0.8011 |
November 07, 2024 | 0.808 |
November 06, 2024 | 0.8361 |
November 05, 2024 | 0.8414 |
November 04, 2024 | 0.8323 |
November 01, 2024 | 0.8125 |
October 31, 2024 | 0.7404 |
October 30, 2024 | 0.814 |
October 29, 2024 | 0.7905 |
October 28, 2024 | 0.8361 |
October 25, 2024 | 0.8361 |
October 24, 2024 | 0.8778 |
October 23, 2024 | 0.8247 |
October 22, 2024 | 0.8102 |
October 21, 2024 | 0.7821 |
October 18, 2024 | 0.7928 |
October 17, 2024 | 0.8049 |
Date | Value |
---|---|
October 16, 2024 | 0.8011 |
October 15, 2024 | 0.7935 |
October 14, 2024 | 0.7973 |
October 11, 2024 | 0.7791 |
October 10, 2024 | 0.7852 |
October 09, 2024 | 0.7776 |
October 08, 2024 | 0.7852 |
October 07, 2024 | 0.7089 |
October 04, 2024 | 0.7168 |
October 03, 2024 | 0.7138 |
October 02, 2024 | 0.7047 |
October 01, 2024 | 0.7009 |
September 30, 2024 | 0.7419 |
September 27, 2024 | 0.6872 |
September 26, 2024 | 0.7313 |
September 25, 2024 | 0.7556 |
September 24, 2024 | 0.7753 |
September 23, 2024 | 0.8049 |
September 20, 2024 | 0.7472 |
September 19, 2024 | 0.7343 |
September 18, 2024 | 0.7282 |
September 17, 2024 | 0.7692 |
September 16, 2024 | 0.767 |
September 13, 2024 | 0.732 |
September 12, 2024 | 0.7753 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4725
Minimum
Jun 28 2022
10.18
Maximum
Jan 29 2024
2.380
Average
2.123
Median
Price to Book Value Benchmarks
AC Immune SA | 2.101 |
CRISPR Therapeutics AG | 2.037 |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | 1.192 |
MoonLake Immunotherapeutics | 6.719 |
Price to Book Value Related Metrics
PS Ratio | 7.837 |
Price | 8.23 |
Earnings Yield | -19.96% |
Market Cap | 8.795M |